{"id":"W3001602950","doi":"10.1097/ogx.0000000000000756","title":"Niraparib in Patients With Newly Diagnosed Advanced Ovarian Cancer","year":2020,"lang":"en","type":"article","venue":"Obstetrical & Gynecological Survey","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; Aalborg Universitet; Pacira BioSciences; Mylan; Fujirebio US; Clovis Oncology; Pacira Pharmaceuticals; Gentofte Hospital; University of South Carolina; Eisai; Thomas Jefferson University; McGill University Health Centre; McGill University; Karyopharm Therapeutics; Roche; GlaxoSmithKline; Takeda Oncology; Rigshospitalet; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Taxane; Epithelial ovarian cancer; Regimen; Ovarian cancer; Chemotherapy; Oncology; Internal medicine; Cytoreductive surgery; Gynecology; Cancer; Breast cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001925385,0.0002889064,0.0007047803,0.0001012367,0.00006534574,0.00002594214,0.0001944821,0.0002495752,0.00271251],"category_scores_gemma":[0.006307676,0.0002035831,0.00009086837,0.001948804,0.0001325705,0.0001131398,0.0000668534,0.0005840119,0.0001097775],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004387037,"about_ca_system_score_gemma":0.0001576555,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002172128,"about_ca_topic_score_gemma":0.0001612155,"domain_scores_codex":[0.9973266,0.0003665915,0.0004950932,0.0006735036,0.0005768242,0.0005614402],"domain_scores_gemma":[0.995713,0.003078507,0.0001386579,0.0002515139,0.0002429867,0.0005753601],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00253287,0.0008303288,0.9748515,0.00001836468,0.00004306494,0.0001207787,0.00007054383,0.0002533954,0.00005578217,0.00007204078,0.001335725,0.01981563],"study_design_scores_gemma":[0.01805937,0.002051737,0.9755167,0.0000362539,0.0000187212,4.561855e-7,0.00001320779,0.0001173823,0.000055565,0.0000567829,0.003794315,0.0002794497],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944757,0.0004998331,0.0003537975,0.002072828,0.0002821096,0.00102722,0.0001144989,0.0001440749,0.001029937],"genre_scores_gemma":[0.9904682,0.00008372183,0.001113366,0.00782477,0.00006274726,0.000186384,0.0001547071,0.00003379096,0.00007231907],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01953618,"threshold_uncertainty_score":0.9981992,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04237501895086256,"score_gpt":0.2939501556881457,"score_spread":0.2515751367372832,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}